|
Volumn 43, Issue 1, 2002, Pages 121-126
|
Treatment of refractory peripheral T-cell lymphoma with denileukin diftitox (ONTAK®)
|
Author keywords
Cutaneous T cell lymphoma; DAB IL2; Denileukin diftitox; ONTAK ; Peripheral T cell lymphoma; Serum soluble IL 2 receptor
|
Indexed keywords
ALPHA INTERFERON;
BEXAROTENE;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DENILEUKIN DIFTITOX;
DEXAMETHASONE;
DIPHTHERIA TOXIN;
DOXORUBICIN;
ETOPOSIDE;
HYBRID PROTEIN;
IFOSFAMIDE;
INTERLEUKIN 2;
ISOTRETINOIN;
LORATADINE;
METHOTREXATE;
METHYLPREDNISOLONE SODIUM SUCCINATE;
NAVELBINE;
PARACETAMOL;
PELDESINE;
PREDNISONE;
PSEUDOEPHEDRINE;
RETINOIC ACID;
TEZACITABINE;
TRIMETREXATE;
VINCRISTINE;
ANTINEOPLASTIC AGENT;
INTERLEUKIN 2 RECEPTOR;
AGED;
ANOREXIA;
ARTICLE;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RECURRENCE;
CASE REPORT;
CHILL;
CONSTIPATION;
CONTROLLED STUDY;
DRUG APPROVAL;
DRUG RESPONSE;
DYSPNEA;
FATIGUE;
HUMAN;
HYPOTHYROIDISM;
LETHARGY;
MALE;
MONOTHERAPY;
MYCOSIS FUNGOIDES;
PLEURA EFFUSION;
PRIORITY JOURNAL;
SKIN LYMPHOMA;
STANDARD;
SYNCOPE;
T CELL LYMPHOMA;
THROMBOCYTOPENIA;
TREATMENT FAILURE;
VERTIGO;
DRUG EFFECT;
ERYTHEMA;
LUNG TUMOR;
LYMPH NODE;
METABOLISM;
NOSE TUMOR;
PATHOLOGY;
PERIPHERAL T CELL LYMPHOMA;
SALVAGE THERAPY;
SKIN TUMOR;
TREATMENT OUTCOME;
AGED;
ANTINEOPLASTIC AGENTS;
DIPHTHERIA TOXIN;
ERYTHEMA;
HUMANS;
INTERLEUKIN-2;
LUNG NEOPLASMS;
LYMPH NODES;
LYMPHOMA, T-CELL, PERIPHERAL;
MALE;
NOSE NEOPLASMS;
RECEPTORS, INTERLEUKIN-2;
RECOMBINANT FUSION PROTEINS;
SALVAGE THERAPY;
SKIN NEOPLASMS;
TREATMENT OUTCOME;
|
EID: 0036123178
PISSN: 10428194
EISSN: None
Source Type: Journal
DOI: 10.1080/10428190210183 Document Type: Article |
Times cited : (52)
|
References (20)
|